眼科治疗中纳米机器人应用的进展和前景
Antonio Átila Menezes Ferreira1, John Hebert da Silva Felix1, Rita Karolinny Chaves de Lima1
1Instituto de Engenharias e Desenvolvimento Sustentável, Universidade da Integração Internacional da Lusofonia Afro-Brasileira, Campus das Auroras, Redenção, Ceará CEP 62790-970, Brazil.
ACS biomaterials science & engineering
|January 17, 2025
概括
微型和纳米技术为治疗眼睛疾病 (如青光眼) 提供了有前途的进展,有可能克服当前治疗方法的局限性. 研究表明,该领域的显著增长,新型纳米粒子增强药物输送,以获得更好的治疗结果.
科学领域:
- 眼科医生 眼科 眼科
- 生物医学工程 生物医学工程
- 材料科学 材料科学 材料科学
背景情况:
- 传统的眼科治疗面临着诸如低生物利用率和副作用等挑战.
- 新兴的微型和纳米技术为眼部疾病管理提供了新的解决方案.
- 青光眼治疗是这些先进的治疗方法的主要重点.
研究的目的:
- 在眼部疾病治疗中对微型和纳米技术应用进行文献统计审查.
- 确定该领域的关键研究趋势,作者和机构.
- 分析用于增强眼疗法的设备和药物输送系统的进步.
主要方法:
- 从科学网络中对385份文档进行了文献计量和文献分析.
- 使用VOSviewer和Bibliometrix软件进行数据分析.
- 专注于与眼科中微型和纳米技术相关的研究.
主要成果:
- 与眼睛疾病的微型和纳米技术相关的科学产出显著增加.
- 英国被确定为研究贡献的领先国家.
- 纳米粒子,纳米微粒和聚合物系统显示出控制,长时间释放药物的潜力.
结论:
- 微型和纳米技术具有显著的潜力,可以彻底改变眼睛疾病的治疗方法,特别是对玻璃眼的治疗.
- 这些技术有可能改善药物输送,生物可用性,并减少副作用.
- 对生物相容性,可扩展性和临床研究的进一步研究对于治疗整合至关重要.
相关概念视频
Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Angle Closure Glaucoma: Treatment
1.6K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.6K
Ophthalmic Drug Delivery Systems
283
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
283


